Aralez Pharmaceuticals (ARZ) Stock Price Down 3.2%

Aralez Pharmaceuticals Inc (TSE:ARZ)’s share price was down 3.2% on Friday . The stock traded as low as C$2.06 and last traded at C$2.11. Approximately 3,960 shares changed hands during trading, a decline of 85% from the average daily volume of 26,053 shares. The stock had previously closed at C$2.18.

Separately, HC Wainwright restated a “buy” rating on shares of Aralez Pharmaceuticals in a report on Monday, February 5th.

The company has a market cap of $115.81 and a price-to-earnings ratio of -1.30.

COPYRIGHT VIOLATION NOTICE: This report was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at

About Aralez Pharmaceuticals

Aralez Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The Company focuses on acquiring, developing and commercializing products in cardiovascular, pain and other areas. The Company’s products include Fibricor, Cambia, Fiorinal, Fiorinal C, Soriatane, Bezalip SR, NeoVisc, Uracyst, Durela, Proferrin, Resultz and Collatamp G.

Receive News & Ratings for Aralez Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aralez Pharmaceuticals and related companies with's FREE daily email newsletter.

Leave a Reply